Lubiprostone
CAS: 136790-76-6
MF: C20H32F2O5
MW: 390.47
EINECS: 634-172-9
MF: C20H32F2O5
MW: 390.47
EINECS: 634-172-9
API407
Quantity
Lubiprostone is a drug that is prescribed as a treatment for acute idiopathic constipation that is associated with bloating, stomach pain and straining in bowel movements.
The drug is prescribed in cases where a patient is experiencing infrequent bowel movements that may persist for about 3 months or a longer period of time without necessarily being resultant of certain medications or diseases.
The drug may also be used to relieve constipation that may result from specific opioid (narcotic) use amongst people who have persistent pain that is not caused by cancer.
Lubiprostone is classified as a laxative and its mechanism of action entails enhancing the flow of fluid into the bowel for easier bowel movements.
Lubiprostone is a bicyclic fatty acid metabolite analog of Prostaglandin E1.
It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms of constipation.
Lubiprostone is indicated for the treatment of acute idiopathic constipation in adult patients.
It is also used as a medication for irritable bowel syndrome which is accompanied by constipation in women who are over 18 years.
